<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
<channel>
<title>Hepatitis Central</title>
<link>http://www.hepatitis-central.com/mt/</link>
<description>Hepatitis C News, Updates and Commentary.</description>
<copyright>Copyright 2012</copyright>
<lastBuildDate>Tue, 21 Feb 2012 10:00:42 -0500</lastBuildDate>
<generator>http://www.movabletype.org/?v=4.25</generator>
<docs>http://blogs.law.harvard.edu/tech/rss</docs> 


<item>
<title>Three Grants to Reduce the Burden of Hepatitis in Asia Awarded</title>
<description>The Bristol-Myers Squibb Foundation has recently awarded three grants in an effort to prevent, diagnose and care for those with Hepatitis B and Hepatitis C in China and India.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/02/three_grants_to.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/02/three_grants_to.html</guid>
<category>General Hepatitis C News/Updates</category>
<pubDate>Tue, 21 Feb 2012 10:00:42 -0500</pubDate>
</item>

<item>
<title>Hepatitis C Relapse Leads to Gilead Woes</title>
<description>Because three quarters of Hepatitis C patients relapsed after stopping Gilead&apos;s GS-7977, the company&apos;s financial profile suffered.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/02/hepatitis_c_rel.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/02/hepatitis_c_rel.html</guid>
<category>General Hepatitis C News/Updates</category>
<pubDate>Mon, 20 Feb 2012 16:23:55 -0500</pubDate>
</item>

<item>
<title>Warning for HIV-Hep C Co-infection: Certain Drugs Don&apos;t Mix with Victrelis!</title>
<description>Since an estimated one third of HIV patients are also infected with Hepatitis C, knowing about the potential interaction between boceprevir and certain HIV medications is imperative.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/02/warning_for_hiv.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/02/warning_for_hiv.html</guid>
<category>General Hepatitis C News/Updates</category>
<pubDate>Wed, 15 Feb 2012 08:16:12 -0500</pubDate>
</item>

<item>
<title>Hepatitis C Survival on Inanimate Objects</title>
<description>We usually think of Hepatitis C as a virus that is passed from person to person. However, most infections occur via an intermediary, inanimate object. Thus, determining the length of time Hepatitis C can survive outside the body is crucial to prevent transmission of this virus.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/02/hepatitis_c_sur.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/02/hepatitis_c_sur.html</guid>
<category>Understanding HCV</category>
<pubDate>Tue, 14 Feb 2012 15:40:00 -0500</pubDate>
</item>

<item>
<title>Can Liver Disease Risk Be Foretold by a Liver Enzyme Test?</title>
<description>Maryland researchers have published a study detailing the usefulness of the ALT liver enzyme test to differentiate between those at high and low risk of having liver disease.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/02/can_liver_disea.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/02/can_liver_disea.html</guid>
<category>General Hepatitis C News/Updates</category>
<pubDate>Wed, 08 Feb 2012 15:43:48 -0500</pubDate>
</item>

<item>
<title>Why Occult Hepatitis B Can Be Hazardous</title>
<description>New research shows that even if Hepatitis B is hidden, it can still cause serious harm.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/02/why_occult_hepa.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/02/why_occult_hepa.html</guid>
<category>Hepatitis B</category>
<pubDate>Tue, 07 Feb 2012 10:03:06 -0500</pubDate>
</item>

<item>
<title>Advancement Made on Thwarting Hep C Replication and Resistance</title>
<description>A prominent UCLA researcher pinpoints the protein that blocks Hepatitis C viral replication and could ultimately end the problem of medication resistance during Hepatitis C therapy.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/02/advancement_mad.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/02/advancement_mad.html</guid>
<category>General Hepatitis C News/Updates</category>
<pubDate>Mon, 06 Feb 2012 09:44:48 -0500</pubDate>
</item>

<item>
<title>Progress in Studying Hep C Powered by Stem Cells</title>
<description>Spearheaded by a research team spanning several respected U.S. universities, stem cells are showing promise in understanding some of the challenges presented by the Hepatitis C virus.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/02/progress_in_stu.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/02/progress_in_stu.html</guid>
<category>General Hepatitis C News/Updates</category>
<pubDate>Mon, 06 Feb 2012 09:38:31 -0500</pubDate>
</item>

<item>
<title>Hepatitis Awareness at the Nail Salon</title>
<description>It&apos;s hard to imagine that intravenous drug use and mani-pedis have much in common, but they both harbor the potential to spread viral hepatitis.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/02/hepatitis_aware_2.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/02/hepatitis_aware_2.html</guid>
<category>Hepatitis C Awareness/Activism</category>
<pubDate>Thu, 02 Feb 2012 12:24:27 -0500</pubDate>
</item>

<item>
<title>Anemia and Hepatitis C Treatment</title>
<description>In opposition to what seems logical, research demonstrates that becoming anemic while on Hepatitis C therapy is not such a bad thing.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/01/anemia_and_hepa.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/01/anemia_and_hepa.html</guid>
<category>General Hepatitis C News/Updates</category>
<pubDate>Tue, 24 Jan 2012 12:05:02 -0500</pubDate>
</item>

<item>
<title>Bristol-Myers Gains Momentum with All-Oral Hep C Therapy</title>
<description>In a recent study, over one third of previous non-responders cleared Hepatitis C with an interferon-free combo of two Bristol-Myers experimental drugs.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/01/bristol-myers_g.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/01/bristol-myers_g.html</guid>
<category>Emerging Hepatitis C Treatments/Therapies</category>
<pubDate>Mon, 23 Jan 2012 09:48:16 -0500</pubDate>
</item>

<item>
<title>Hepatitis C Gains Access to Brain Cells</title>
<description>Helping to explain why Hepatitis C can cause extrahepatic manifestations (problems outside of the liver), American researchers confirmed that certain brain cells are susceptible to the Hepatitis C virus.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/01/hepatitis_c_gai.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/01/hepatitis_c_gai.html</guid>
<category>General Hepatitis C News/Updates</category>
<pubDate>Mon, 23 Jan 2012 09:47:07 -0500</pubDate>
</item>

<item>
<title>Liver Cancer More Likely with Hep C and Fatty Liver</title>
<description>Two separate Mayo Clinic studies find that liver cancer rates are magnified by obesity and Hepatitis C infection.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/01/liver_cancer_mo.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/01/liver_cancer_mo.html</guid>
<category>General Hepatitis C News/Updates</category>
<pubDate>Fri, 13 Jan 2012 16:21:44 -0500</pubDate>
</item>

<item>
<title>Novel Hep C Vaccine in Phase 1 Trial</title>
<description>By targeting the inside of a Hepatitis C viral cell for a greater T-cell response, Oxford researchers are one step closer to a vaccine for preventing Hepatitis C infection.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/01/novel_hep_c_vac.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/01/novel_hep_c_vac.html</guid>
<category>General Hepatitis C News/Updates</category>
<pubDate>Mon, 09 Jan 2012 15:18:22 -0500</pubDate>
</item>

<item>
<title>Fast-Track Given to Hepatitis C Drug ACH-1625</title>
<description>Likely due to its convenient dosing, safety and tolerability, Achillion&apos;s ACH-1625 has been awarded fast-track status by FDA.</description>
<link>http://www.hepatitis-central.com/mt/archives/2012/01/fast-track_give.html</link>
<guid>http://www.hepatitis-central.com/mt/archives/2012/01/fast-track_give.html</guid>
<category>Emerging Hepatitis C Treatments/Therapies</category>
<pubDate>Mon, 09 Jan 2012 11:00:38 -0500</pubDate>
</item>


</channel>
</rss>
